Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Zabini, D; Crnkovic, S; Xu, H; Tscherner, M; Ghanim, B; Klepetko, W; Olschewski, A; Kwapiszewska, G; Marsh, LM.
High-mobility group box-1 induces vascular remodelling processes via c-Jun activation.
J Cell Mol Med. 2015; 19(5):1151-1161 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Crnkovic Slaven
Kwapiszewska-Marsh Grazyna
Marsh Leigh
Olschewski Andrea
Tscherner Maria
XU Hui
Zabini Diana
Altmetrics:

Dimensions Citations:

Plum Analytics:
Number of Figures: 7
| | | | | | |
Abstract:
Extracellular high-mobility group box-1 (HMGB1) acts as a signalling molecule during inflammation, cell differentiation and angiogenesis. Increased abundance of HMGB1 is associated with several pathological disorders such as cancer, asthma and chronic obstructive pulmonary disease (COPD). In this study, we investigated the relevance of HMGB1 in the pathological remodelling present in patients with idiopathic pulmonary arterial hypertension (IPAH) and pulmonary hypertension (PH) associated with COPD. Remodelled vessels present in COPD with PH and IPAH lung samples were often surrounded by HMGB1-positive cells. Increased HMGB1 serum levels were detected in both patient populations compared to control samples. The effects of physiological HMGB1 concentrations were then examined on cellular responses in vitro. HMGB1 enhanced proliferation of pulmonary arterial smooth muscle cells (PASMC) and primary human arterial endothelial cells (PAEC). HMGB1 stimulated p38, extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) phosphorylation. Furthermore, activation of the downstream AP-1 complex proteins c-Fos and c-Jun was observed. Silencing of c-Jun ablated the HMGB1-induced proliferation in PASMC. Thus, an inflammatory component such as HMGB1 can contribute to PASMC and PAEC proliferation and therefore potentially to vascular remodelling and PH pathogenesis. © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Blotting, Western -
Cell Proliferation - drug effects
Cell Proliferation - genetics
Cells, Cultured -
Endothelial Cells - drug effects
Endothelial Cells - metabolism
Enzyme Activation - drug effects
Familial Primary Pulmonary Hypertension - genetics
Familial Primary Pulmonary Hypertension - metabolism
Familial Primary Pulmonary Hypertension - pathology
Female -
HMGB1 Protein - blood
HMGB1 Protein - metabolism
HMGB1 Protein - pharmacology
Humans -
Hypertension, Pulmonary - genetics
Hypertension, Pulmonary - metabolism
Hypertension, Pulmonary - pathology
Immunohistochemistry -
JNK Mitogen-Activated Protein Kinases - genetics
JNK Mitogen-Activated Protein Kinases - metabolism
Male -
Middle Aged -
Muscle, Smooth, Vascular - cytology
Myocytes, Smooth Muscle - drug effects
Myocytes, Smooth Muscle - metabolism
Pulmonary Artery - cytology
RNA Interference -
Receptor for Advanced Glycation End Products - genetics
Receptor for Advanced Glycation End Products - metabolism
Reverse Transcriptase Polymerase Chain Reaction -
Signal Transduction - drug effects
Signal Transduction - genetics
Toll-Like Receptor 4 - genetics
Toll-Like Receptor 4 - metabolism
Vascular Remodeling - drug effects
Vascular Remodeling - genetics
Vascular Remodeling - physiology

Find related publications in this database (Keywords)
alarmins
HMGB1
inflammation
proliferation
pulmonary hypertension
© Meduni Graz Impressum